Direct thrombin inhibitors are anticoagulant medications that specifically target and inhibit thrombin, an enzyme essential for blood clot formation. They are used to prevent and treat thromboembolic disorders and offer an alternative to traditional anticoagulants like warfarin, with the advantage of having more predictable pharmacokinetics and fewer dietary interactions.